These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

428 related items for PubMed ID: 15383024

  • 1. Photochemical treatment of platelet concentrates with amotosalen and long-wavelength ultraviolet light inactivates a broad spectrum of pathogenic bacteria.
    Lin L, Dikeman R, Molini B, Lukehart SA, Lane R, Dupuis K, Metzel P, Corash L.
    Transfusion; 2004 Oct; 44(10):1496-504. PubMed ID: 15383024
    [Abstract] [Full Text] [Related]

  • 2. Photochemical treatment of platelet concentrates with amotosalen hydrochloride and ultraviolet A light inactivates free and latent cytomegalovirus in a murine transfusion model.
    Jordan CT, Saakadze N, Newman JL, Lezhava LJ, Maiers TT, Hillyer WM, Roback JD, Hillyer CD.
    Transfusion; 2004 Aug; 44(8):1159-65. PubMed ID: 15265119
    [Abstract] [Full Text] [Related]

  • 3. Photochemical inactivation with amotosalen and long-wavelength ultraviolet light of Plasmodium and Babesia in platelet and plasma components.
    Grellier P, Benach J, Labaied M, Charneau S, Gil H, Monsalve G, Alfonso R, Sawyer L, Lin L, Steiert M, Dupuis K.
    Transfusion; 2008 Aug; 48(8):1676-84. PubMed ID: 18503613
    [Abstract] [Full Text] [Related]

  • 4. Amotosalen interactions with platelet and plasma components: absence of neoantigen formation after photochemical treatment.
    Lin L, Conlan MG, Tessman J, Cimino G, Porter S.
    Transfusion; 2005 Oct; 45(10):1610-20. PubMed ID: 16181212
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. In vitro photochemical inactivation of cell-associated human T-cell leukemia virus Type I and II in human platelet concentrates and plasma by use of amotosalen.
    Jauvin V, Alfonso RD, Guillemain B, Dupuis K, Fleury HJ.
    Transfusion; 2005 Jul; 45(7):1151-9. PubMed ID: 15987361
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Inactivation of parvovirus B19 in human platelet concentrates by treatment with amotosalen and ultraviolet A illumination.
    Sawyer L, Hanson D, Castro G, Luckett W, Dubensky TW, Stassinopoulos A.
    Transfusion; 2007 Jun; 47(6):1062-70. PubMed ID: 17524098
    [Abstract] [Full Text] [Related]

  • 13. Assessment of safety in neonates for transfusion of platelets and plasma prepared with amotosalen photochemical pathogen inactivation treatment by a 1-month intravenous toxicity study in neonatal rats.
    Ciaravino V, Hanover J, Lin L, Sullivan T, Corash L.
    Transfusion; 2009 May; 49(5):985-94. PubMed ID: 19175545
    [Abstract] [Full Text] [Related]

  • 14. The efficacy of photochemical treatment with amotosalen HCl and ultraviolet A (INTERCEPT) for inactivation of Trypanosoma cruzi in pooled buffy-coat platelets.
    Castro E, Gironés N, Bueno JL, Carrión J, Lin L, Fresno M.
    Transfusion; 2007 Mar; 47(3):434-41. PubMed ID: 17319823
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of BacT/ALERT plastic culture bottles for use in testing pooled whole blood-derived leukoreduced platelet-rich plasma platelets with a single contaminated unit.
    Brecher ME, Hay SN, Rose AD, Rothenberg SJ.
    Transfusion; 2005 Sep; 45(9):1512-7. PubMed ID: 16131385
    [Abstract] [Full Text] [Related]

  • 16. Clinical safety of platelets photochemically treated with amotosalen HCl and ultraviolet A light for pathogen inactivation: the SPRINT trial.
    Snyder E, McCullough J, Slichter SJ, Strauss RG, Lopez-Plaza I, Lin JS, Corash L, Conlan MG, SPRINT Study Group.
    Transfusion; 2005 Dec; 45(12):1864-75. PubMed ID: 16371039
    [Abstract] [Full Text] [Related]

  • 17. In-house validation of the BACTEC 9240 blood culture system for detection of bacterial contamination in platelet concentrates.
    Dunne WM, Case LK, Isgriggs L, Lublin DM.
    Transfusion; 2005 Jul; 45(7):1138-42. PubMed ID: 15987359
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of in vitro storage properties of prestorage pooled whole blood-derived platelets suspended in 100 percent plasma and treated with amotosalen and long-wavelength ultraviolet light.
    Wagner SJ, Skripchenko A, Myrup A, Awatefe H, Thompson-Montgomery D, Moroff G, Carmichael P, Lin L.
    Transfusion; 2009 Apr; 49(4):704-10. PubMed ID: 19171001
    [Abstract] [Full Text] [Related]

  • 19. Implementation of the INTERCEPT Blood System for Platelets into routine blood bank manufacturing procedures: evaluation of apheresis platelets.
    Janetzko K, Lin L, Eichler H, Mayaudon V, Flament J, Klüter H.
    Vox Sang; 2004 May; 86(4):239-45. PubMed ID: 15144528
    [Abstract] [Full Text] [Related]

  • 20. Sterilization of platelet concentrates at production scale by irradiation with short-wave ultraviolet light.
    Mohr H, Gravemann U, Bayer A, Müller TH.
    Transfusion; 2009 Sep; 49(9):1956-63. PubMed ID: 19497057
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.